Short Interest in Bonk, Inc. (NASDAQ:BNKK) Increases By 761.1%

Bonk, Inc. (NASDAQ:BNKK) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totaling 834,243 shares, a growth of 761.1% from the April 30th total of 96,882 shares. Approximately 21.5% of the company’s shares are short sold. Based on an average trading volume of 724,730 shares, the short-interest ratio is currently 1.2 days.

Insider Buying and Selling

In other news, Director Mitchell Austin Rudy bought 31,055 shares of the stock in a transaction on Thursday, April 9th. The stock was purchased at an average cost of $2.82 per share, with a total value of $87,575.10. Following the purchase, the director owned 44,198 shares of the company’s stock, valued at approximately $124,638.36. The trade was a 236.29% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Insiders own 51.60% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of BNKK. Geode Capital Management LLC acquired a new position in shares of Bonk during the fourth quarter worth about $128,000. Jane Street Group LLC purchased a new stake in shares of Bonk during the fourth quarter valued at approximately $96,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Bonk during the fourth quarter valued at approximately $37,000. Finally, State Street Corp purchased a new stake in shares of Bonk during the fourth quarter valued at approximately $33,000. Institutional investors and hedge funds own 12.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on BNKK. Wall Street Zen cut shares of Bonk from a “hold” rating to a “sell” rating in a research note on Saturday. Weiss Ratings lowered Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Bonk Stock Up 9.7%

BNKK opened at $1.93 on Friday. Bonk has a 52-week low of $1.53 and a 52-week high of $46.90. The company has a 50 day moving average of $2.43 and a two-hundred day moving average of $3.56. The company has a market cap of $15.44 million, a P/E ratio of -0.42 and a beta of 1.97.

Bonk (NASDAQ:BNKK) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. The business had revenue of $0.79 million for the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.